Radiodermatitis. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Intervention group: Topical Erythropoietin cream is made by the operator in the laboratory. Patients with breast cancer referred to the center Radiation therapy is included in the stud
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Female patients older than 18 years patients with positive histology confirm invasive and localized breast cancer Patients who candidates for adjuvant radiotherapy after surgery (breast conserving or mastectomy) Adequate literacy to fill out a consent form, understand the study, use the drug, report pain and possible side effects
Exclusion criteria
Exclusion criteria: Inflammatory or metastatic carcinoma Extensive skin diseases Connective tissue diseases known sensitivity to drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute radiation dermatitis. Timepoint: Weekly during radiotherapy and two weeks after the end of radiotherapy. Method of measurement: Based on the Radiation Therapy Oncology Group and the European Organization for Research and Treatment of Cancer (RTOG / EORTC). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyede Sahar Mesbah
Yazd University of Medical Sciences
Outcome results
None listed